ARTICLE | Company News
DelSite, Nanotherapeutics deal
October 12, 2009 7:00 AM UTC
Nanotherapeutics acquired DelSite's GelVac drug delivery assets in a Chapter 7 bankruptcy sale for $50,000. Nanotherapeutics gains the GelSite delivery polymer and DelSite's Phase I avian influenza (...